Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
25.8M
-
Shares change
-
-3.09M
-
Total reported value, excl. options
-
$49.8M
-
Value change
-
-$8.78M
-
Put/Call ratio
-
1
-
Number of buys
-
39
-
Number of sells
-
-40
-
Price
-
$1.93
Significant Holders of Kyverna Therapeutics, Inc. - COM (KYTX) as of Q1 2025
104 filings reported holding KYTX - Kyverna Therapeutics, Inc. - COM as of Q1 2025.
Kyverna Therapeutics, Inc. - COM (KYTX) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.8M shares
.
Largest 10 shareholders include Vida Ventures Advisors, LLC (4.52M shares), GILEAD SCIENCES, INC. (4.13M shares), Bain Capital Life Sciences Investors, LLC (3.37M shares), Novo Holdings A/S (1.85M shares), BlackRock, Inc. (1.68M shares), VANGUARD GROUP INC (1.3M shares), CITADEL ADVISORS LLC (994K shares), Insight Holdings Group, LLC (989K shares), FRANKLIN RESOURCES INC (692K shares), and MBB PUBLIC MARKETS I LLC (614K shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.